Carr M[au] - Search Results

Year	Number of Results
1923	2
1924	3
1925	3
1945	1
1946	1
1948	7
1951	2
1952	1
1953	1
1955	2
1956	1
1957	4
1958	2
1959	2
1960	5
1961	1
1962	3
1964	2
1965	2
1967	4
1969	1
1970	2
1971	2
1972	9
1973	5
1974	3
1975	8
1976	4
1977	5
1978	5
1979	7
1980	3
1981	3
1982	3
1983	9
1984	7
1985	6
1986	11
1987	17
1988	13
1989	17
1990	16
1991	13
1992	14
1993	14
1994	31
1995	26
1996	32
1997	20
1998	23
1999	20
2000	16
2001	38
2002	30
2003	39
2004	45
2005	39
2006	36
2007	30
2008	35
2009	39
2010	41
2011	50
2012	41
2013	36
2014	42
2015	43
2016	65
2017	66
2018	76
2019	84
2020	103
2021	116
2022	113
2023	120
2024	120
2025	106
2026	6

1

Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment.

Wysham C, Bajaj HS, Del Prato S, Franco DR, Kiyosue A, Dahl D, Zhou C, Carr MC, Case M, Firmino Gonçalves L; QWINT-2 Investigators. Wysham C, et al. Among authors: carr mc. N Engl J Med. 2024 Dec 12;391(23):2201-2211. doi: 10.1056/NEJMoa2403953. Epub 2024 Sep 10. N Engl J Med. 2024. PMID: 39254740 Clinical Trial.

2

Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy.

Rosenstock J, Bailey T, Connery L, Miller E, Desouza C, Wang Q, Leohr J, Knights A, Carr MC, Child CJ; QWINT-1 trial investigators. Rosenstock J, et al. Among authors: carr mc. N Engl J Med. 2025 Jul 24;393(4):325-335. doi: 10.1056/NEJMoa2502796. Epub 2025 Jun 22. N Engl J Med. 2025. PMID: 40548694 Clinical Trial.

3

A Review of the Clinical Utilization of Oral Antibacterial Therapy in the Treatment of Bone Infections in Adults.

Haddad N, Ajaz J, Mansour L, Kasemodel R, Jarvis J, Jarad J, Gorski H, Carr M. Haddad N, et al. Among authors: carr m. Antibiotics (Basel). 2023 Dec 19;13(1):4. doi: 10.3390/antibiotics13010004. Antibiotics (Basel). 2023. PMID: 38275315 Free PMC article. Review.

4

Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes.

Wright AK, Carr MJ, Kontopantelis E, Leelarathna L, Thabit H, Emsley R, Buchan I, Mamas MA, van Staa TP, Sattar N, Ashcroft DM, Rutter MK. Wright AK, et al. Among authors: carr mj. Diabetes Care. 2022 Apr 1;45(4):909-918. doi: 10.2337/dc21-1113. Diabetes Care. 2022. PMID: 35100355 Free article.

5

Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial.

Bergenstal RM, Weinstock RS, Mathieu C, Onishi Y, Vijayanagaram V, Katz ML, Carr MC, Chang AM. Bergenstal RM, et al. Among authors: carr mc. Lancet. 2024 Sep 21;404(10458):1132-1142. doi: 10.1016/S0140-6736(24)01804-X. Epub 2024 Sep 10. Lancet. 2024. PMID: 39270686 Clinical Trial.

6

Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme.

Bergenstal RM, Philis-Tsimikas A, Wysham C, Carr MC, Bue-Valleskey JM, Botros FT, Blevins T, Rosenstock J. Bergenstal RM, et al. Among authors: carr mc. Diabetes Obes Metab. 2024 Aug;26(8):3020-3030. doi: 10.1111/dom.15604. Epub 2024 Apr 28. Diabetes Obes Metab. 2024. PMID: 38679838 Review.

7

Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study.

Mok PLH, Carr MJ, Guthrie B, Morales DR, Sheikh A, Elliott RA, Camacho EM, van Staa T, Avery AJ, Ashcroft DM. Mok PLH, et al. Among authors: carr mj. BMJ. 2024 Apr 17;385:e076268. doi: 10.1136/bmj-2023-076268. BMJ. 2024. PMID: 38631737 Free PMC article.

8

New strategies for the cognitive science of dreaming.

Mallett R, Konkoly KR, Nielsen T, Carr M, Paller KA. Mallett R, et al. Among authors: carr m. Trends Cogn Sci. 2024 Dec;28(12):1105-1117. doi: 10.1016/j.tics.2024.10.004. Epub 2024 Nov 4. Trends Cogn Sci. 2024. PMID: 39500684 Free PMC article. Review.

9

Traumatic Central Cord Syndrome.

Carr MT, Harrop JS, Houten JK. Carr MT, et al. Clin Spine Surg. 2024 Nov 1;37(9):379-387. doi: 10.1097/BSD.0000000000001703. Epub 2024 Sep 30. Clin Spine Surg. 2024. PMID: 39480046 Review.

10

Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial.

Blevins T, Dahl D, Pérez Manghi FC, Murthy S, Ortiz Carrasquillo R, Li X, Chang AM, Carr MC, Katz M. Blevins T, et al. Among authors: carr mc. Lancet. 2025 Jun 28;405(10497):2290-2301. doi: 10.1016/S0140-6736(25)01069-4. Epub 2025 Jun 22. Lancet. 2025. PMID: 40562048 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,768 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,768 results

Results by year